| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1263423B1 Composition for the prevention and/or treatment of vascular diseases, consisting of propionyl l-carnitine and coenzyme q10 |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1227859B1 Neurophilin ligands for treating ocular conditions |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1148881B1 USE OF PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1033979B1 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816524A Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816339A Metabolite of quetiapine |
| 08/09/2006 | CN1816335A Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
| 08/09/2006 | CN1816332A 3-aminomethyl-pyrrolidines as N-type calcium channel blockers |
| 08/09/2006 | CN1816284A Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1814587A Method for preparing N-[2-[s-c4-methoxy-benzyl) sulfenyl]-3,5-dimethyl amantadine hydro chloride |
| 08/09/2006 | CN1814301A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1814276A Nerve-protection function of thymosin beta 10 |
| 08/09/2006 | CN1814271A Chinese medicine vemedy for treating globus hysteritis and preparing method |
| 08/09/2006 | CN1814237A Shiyiwi nerves-soothing capsule |
| 08/09/2006 | CN1814183A Chinese medicine capsule for treating epilepsy |
| 08/09/2006 | CN1814172A Chinese medicine for treating headache resulted from function pathology |
| 08/09/2006 | CN1814162A Pulse-promoting large-volume injecta and preparing method |
| 08/09/2006 | CN1814040A Compound liquid capsule of Chinese caterpillar fungus, preparing method and quality control method |
| 08/09/2006 | CN1814026A External-ase medicine formula good for intelligence for examination and medicated plaster |
| 08/09/2006 | CN1814021A Ointment of diminishing gore and preparing method |
| 08/09/2006 | CN1814014A Chinese medicine preparation for treating insomnia |
| 08/09/2006 | CN1813981A Oral medicine preparation for treating apoplexy and sequela |
| 08/09/2006 | CN1813966A Oral Chinese-medicine preparation for treating neuropathic pain |
| 08/09/2006 | CN1813959A Health-care medicated pillow |
| 08/09/2006 | CN1813927A Chinese medicine composition |
| 08/09/2006 | CN1813920A Medicinal composition with synergistic effect |
| 08/09/2006 | CN1813900A Kadsura longipedunculata lignin extract and its preparing method and use |
| 08/09/2006 | CN1813884A Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer |
| 08/09/2006 | CN1813873A Medicine for treating diabete peripheral herve pathology |
| 08/09/2006 | CN1813855A Medicine for treating cardio-cerebrovascular disease |
| 08/09/2006 | CN1813842A Chinese medicine beverage for treating anhypnia |
| 08/09/2006 | CN1813834A Method for preparing total flavone extract of many prickle acanthopanax |
| 08/09/2006 | CN1813825A Ginkgolide emulsion for injection |
| 08/09/2006 | CN1813820A Chinese medicine glossy ganoderma particle and its preparing process |
| 08/09/2006 | CN1813797A Medicinal composition, and its preparing method and use |
| 08/09/2006 | CN1813789A New action of rosa polysaccharides |
| 08/09/2006 | CN1813745A 5-HT 1a receptor subtype agonists |
| 08/09/2006 | CN1813740A Sublingual pellicles containing naloxone hydrochloride and preparing method thereof |
| 08/09/2006 | CN1813739A Nalmefene hydro chloride lyophilized powder formulation for injection |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1813715A Ginkgolide B dropping pill and its preparing method |
| 08/09/2006 | CN1813714A Ginkgolide B soft capsule and its preparing method |
| 08/09/2006 | CN1813690A Asarone injection emulsion and its preparing method |
| 08/09/2006 | CN1813689A Asarone fatty emulsion and its preparing method |
| 08/09/2006 | CN1813675A Galanthamine hydrobromide composition and its preparing method |
| 08/09/2006 | CN1813555A Substituted tea for clearing heat, relieving summer heat, removing alcohol, diuresis and relieving struct and its production method |
| 08/09/2006 | CN1268762C Corn peptide and its preparation and use |
| 08/09/2006 | CN1268744C Novel neurotrophic factors |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268610C Sulfonamide derivatives |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268388C Volatile extraction for promoting falling asleep and improving sleep quality and its product for external use |
| 08/09/2006 | CN1268387C Oral liquid capable of relieving or neutralizing the effect of alcohol and its preparing method |
| 08/09/2006 | CN1268385C Chinese medicinal for epilepsy and insanity |
| 08/09/2006 | CN1268373C Chinese herbal medicine recipe for curing psychosis |
| 08/09/2006 | CN1268343C Compositions of asiatic centella and Hypericum perforatum extracts and its antidepressant action |
| 08/09/2006 | CN1268341C Tubiflorous desert cistanche preparing containing phenethyl alcohol glycoside and its preparing process and use |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/09/2006 | CN1268338C Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268332C Kappa opiate agonists for treatment of bladder diseases |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268326C Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 08/08/2006 | US7087785 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087757 Phenyl-substituted imidazopyridines |
| 08/08/2006 | US7087756 6-(4-Dimethylaminomethyl-phenyl)-3-phenyl-5H-isoxazolo[4,5-c]pyridine-4-one and 6-[4-(2-Methoxy-ethoxymethyl)-phenyl]-5-methyl-3-phenyl-5H-isoxazolo[4,5-c]pyridin-4-one; use treating Parkinson's disease |
| 08/08/2006 | US7087754 Parkinson's disease; antidepressants; cognition activators; analgesics; brain disorders |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087648 Methods for modulating macrophage proliferation using polyamine analogs |
| 08/08/2006 | US7087647 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 08/08/2006 | US7087643 Side effect reduction of diabetes, strokes, multiple sclerosis |
| 08/08/2006 | US7087640 Substance with sedative effect |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |